NCT07342478
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07342478
Title ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Newave Pharmaceutical Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Orchard Healthcare Research RECRUITING Skokie Illinois 60077 United States Details
The Center for Cancer and Blood Disorders-Bethesda RECRUITING Bethesda Maryland 20817 United States Details
Optum Medical Group (Rhodes) P.C. RECRUITING Las Vegas Nevada 89102 United States Details
Duke Adult Blood and Marrow Clinic RECRUITING Durham North Carolina 27705 United States Details
OSU Comprehensive Cancer Center NOT_YET_RECRUITING Columbus Ohio 43210 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15213 United States Details
Medical Oncology Associates - Spokane RECRUITING Spokane Washington 99208 United States Details
Institut Bergonié RECRUITING Bordeaux 33076 France Details
Centre Hospitalier Le Mans RECRUITING Le Mans 72037 France Details
CHRU Tours Bretonneau RECRUITING Tours 37000 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field